This contract involves the ongoing supply of various medications, including general medications, ready-to-use drugs, contrast agents, anti-tuberculosis drugs, infusion fluids, various medications, anticoagulants, anti-infectives, antibiotics (ciprofloxacin, ceftriaxone), and prednisolone. The supply
Tender closed on 24 Jun 2025. Awaiting award.
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.
